BIO-TECHNE Corp Other Comprehensive Income (Loss), Net of Tax
BIO-TECHNE Corp (TECH) reported Other Comprehensive Income (Loss), Net of Tax of -$10.70 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-24.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-24
- BIO-TECHNE Corp other comprehensive income (loss), net of tax for the quarter ending 2026-06-30 was -$3.72M, a 116.80% decline year-over-year.
- BIO-TECHNE Corp other comprehensive income (loss), net of tax for the quarter ending 2026-03-31 was -$4.51M, a 225.40% decline year-over-year.
- BIO-TECHNE Corp other comprehensive income (loss), net of tax for the quarter ending 2025-12-31 was $2.05M.
- BIO-TECHNE Corp other comprehensive income (loss), net of tax for the quarter ending 2025-09-30 was -$4.51M, a 124.77% decline year-over-year.
- BIO-TECHNE Corp other comprehensive income (loss), net of tax for fiscal 2026 was -$10.70M, a 158.04% decline from fiscal 2025.
- BIO-TECHNE Corp other comprehensive income (loss), net of tax for fiscal 2025 was $18.44M.
- BIO-TECHNE Corp other comprehensive income (loss), net of tax for fiscal 2024 was -$12.25M, a 234.59% decline from fiscal 2023.
- BIO-TECHNE Corp other comprehensive income (loss), net of tax for fiscal 2023 was $9.10M.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 6 month as first filed | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$3.72M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-24 | -$8.24M derived: sum of 2 quarters · filed 2026-08-24 | -$6.18M derived: sum of 3 quarters · filed 2026-08-24 | -$10.70M 10-K · filed 2026-08-24 | |
| 2026-03-31 | -$4.51M 10-Q · filed 2026-05-06 | -$2.46M derived: sum of 2 quarters · filed 2026-05-06 | -$6.98M 10-Q · filed 2026-05-06 | $15.20M derived: sum of 4 quarters · filed 2026-08-24 | |
| 2025-12-31 | $2.05M 10-Q · filed 2026-05-06 | -$2.46M 10-Q · filed 2026-02-04 | $19.71M derived: sum of 3 quarters · filed 2026-08-24 | $23.31M derived: sum of 4 quarters · filed 2026-08-24 | |
| 2025-09-30 | -$4.51M 10-Q · filed 2026-05-06 | $17.66M derived: sum of 2 quarters · filed 2026-08-24 | $21.25M derived: sum of 3 quarters · filed 2026-08-24 | -$4.31M derived: sum of 4 quarters · filed 2026-08-24 | |
| 2025-06-30 | $22.17M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-24 | $25.77M derived: sum of 2 quarters · filed 2026-08-24 | $207.00K derived: sum of 3 quarters · filed 2026-08-24 | $18.44M 10-K · filed 2026-08-24 | |
| 2025-03-31 | $3.60M 10-Q · filed 2026-05-06 | -$21.96M derived: sum of 2 quarters · filed 2026-05-06 | -$3.74M 10-Q · filed 2026-05-06 | -$6.75M derived: sum of 4 quarters · filed 2026-08-24 | |
| 2024-12-31 | -$25.56M 10-Q · filed 2026-05-06 | -$7.33M 10-Q · filed 2026-02-04 | -$10.34M derived: sum of 3 quarters · filed 2026-08-24 | -$21.99M derived: sum of 4 quarters · filed 2026-08-24 | |
| 2024-09-30 | $18.23M 10-Q · filed 2026-05-06 | $15.22M derived: sum of 2 quarters · filed 2026-08-24 | $3.57M derived: sum of 3 quarters · filed 2026-08-24 | $17.93M derived: sum of 4 quarters · filed 2026-08-24 | |
| 2024-06-30 | -$3.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-24 | -$14.65M derived: sum of 2 quarters · filed 2026-08-24 | -$300.00K derived: sum of 3 quarters · filed 2026-08-24 | -$12.25M 10-K · filed 2026-08-24 | |
| 2024-03-31 | -$11.65M 10-Q · filed 2025-05-08 | $2.71M derived: sum of 2 quarters · filed 2025-05-08 | -$9.24M 10-Q · filed 2025-05-08 | -$1.76M derived: sum of 4 quarters · filed 2025-08-22 | |
| 2023-12-31 | $14.36M 10-Q · filed 2025-02-06 | $2.40M 10-Q · filed 2025-02-06 | $9.89M derived: sum of 3 quarters · filed 2025-08-22 | $11.46M derived: sum of 4 quarters · filed 2025-08-22 | |
| 2023-09-30 | -$11.95M 10-Q · filed 2024-11-05 | -$4.46M derived: sum of 2 quarters · filed 2025-08-22 | -$2.89M derived: sum of 3 quarters · filed 2025-08-22 | $13.79M derived: sum of 4 quarters · filed 2025-08-22 | |
| 2023-06-30 | $7.49M derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-22 | $9.06M derived: sum of 2 quarters · filed 2025-08-22 | $25.75M derived: sum of 3 quarters · filed 2025-08-22 | $9.10M 10-K · filed 2025-08-22 | |
| 2023-03-31 | $1.57M 10-Q · filed 2024-05-06 | $18.26M derived: sum of 2 quarters · filed 2024-05-06 | $1.62M 10-Q · filed 2024-05-06 | -$18.54M derived: sum of 4 quarters · filed 2024-08-22 | |
| 2022-12-31 | $16.68M 10-Q · filed 2024-02-07 | $42.00K 10-Q · filed 2024-02-07 | -$20.11M derived: sum of 3 quarters · filed 2024-08-22 | -$15.78M derived: sum of 4 quarters · filed 2024-08-22 | |
| 2022-09-30 | -$16.64M 10-Q · filed 2023-11-07 | -$36.79M derived: sum of 2 quarters · filed 2024-08-22 | -$32.47M derived: sum of 3 quarters · filed 2024-08-22 | -$27.66M derived: sum of 4 quarters · filed 2024-08-22 | |
| 2022-06-30 | -$20.15M derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-22 | -$15.82M derived: sum of 2 quarters · filed 2024-08-22 | -$11.02M derived: sum of 3 quarters · filed 2024-08-22 | -$17.98M 10-K · filed 2024-08-22 | |
| 2022-03-31 | $4.33M 10-Q · filed 2023-05-08 | $9.14M derived: sum of 2 quarters · filed 2023-05-08 | $2.17M 10-Q · filed 2023-05-08 | $8.99M derived: sum of 4 quarters · filed 2023-08-23 | |
| 2021-12-31 | $4.81M 10-Q · filed 2023-05-08 | -$2.16M 10-Q · filed 2023-02-07 | $4.67M derived: sum of 3 quarters · filed 2023-08-23 | $4.81M derived: sum of 4 quarters · filed 2023-08-23 | |
| 2021-09-30 | -$6.96M 10-Q · filed 2023-05-08 | -$143.00K derived: sum of 2 quarters · filed 2023-08-23 | $3.00K derived: sum of 3 quarters · filed 2023-08-23 | $18.99M derived: sum of 4 quarters · filed 2023-08-23 | |
| 2021-06-30 | $6.82M derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-23 | $6.97M derived: sum of 2 quarters · filed 2023-08-23 | $25.95M derived: sum of 3 quarters · filed 2023-08-23 | $40.01M 10-K · filed 2023-08-23 | |
| 2021-03-31 | $146.00K 10-Q · filed 2022-05-09 | $19.13M derived: sum of 2 quarters · filed 2022-05-09 | $33.19M 10-Q · filed 2022-05-09 | $39.45M derived: sum of 4 quarters · filed 2022-08-24 | |
| 2020-12-31 | $18.99M 10-Q · filed 2022-05-09 | $33.04M 10-Q · filed 2022-02-07 | $39.30M derived: sum of 3 quarters · filed 2022-08-24 | $14.20M derived: sum of 4 quarters · filed 2022-08-24 | |
| 2020-09-30 | $14.06M 10-Q · filed 2022-05-09 | $20.32M derived: sum of 2 quarters · filed 2022-08-24 | -$4.79M derived: sum of 3 quarters · filed 2022-08-24 | $8.48M derived: sum of 4 quarters · filed 2022-08-24 | |
| 2020-06-30 | $6.26M derived: 10-K 12 month − 10-Q 9 month · filed 2022-08-24 | -$18.85M derived: sum of 2 quarters · filed 2022-08-24 | -$5.57M derived: sum of 3 quarters · filed 2022-08-24 | -$13.68M 10-K · filed 2022-08-24 | |
| 2020-03-31 | -$25.11M 10-Q · filed 2021-05-07 | -$11.83M derived: sum of 2 quarters · filed 2021-05-07 | -$19.94M 10-Q · filed 2021-05-07 | ||
| 2019-12-31 | $13.28M 10-Q · filed 2021-02-08 | $5.17M 10-Q · filed 2021-02-08 | |||
| 2019-06-30 | -$14.02M 10-K · filed 2021-08-25 | ||||
| 2017-06-30 | $16.36M derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-07 | $18.28M derived: sum of 2 quarters · filed 2017-09-07 | $15.00M derived: sum of 3 quarters · filed 2017-09-07 | $21.47M 10-K · filed 2017-09-07 | |
| 2017-03-31 | $1.93M 10-Q · filed 2017-05-10 | -$1.36M derived: sum of 2 quarters · filed 2017-05-10 | $5.11M 10-Q · filed 2017-05-10 | $11.17M derived: sum of 4 quarters · filed 2017-09-07 | |
| 2016-12-31 | -$3.29M 10-Q · filed 2017-02-09 | $3.19M 10-Q · filed 2017-02-09 | $9.25M derived: sum of 3 quarters · filed 2017-09-07 | -$15.71M derived: sum of 4 quarters · filed 2017-09-07 | |
| 2016-09-30 | $6.48M 10-Q · filed 2016-11-09 | $12.54M derived: sum of 2 quarters · filed 2017-09-07 | -$12.42M derived: sum of 3 quarters · filed 2017-09-07 | -$10.33M derived: sum of 4 quarters · filed 2017-09-07 | |
| 2016-06-30 | $6.05M derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-07 | -$18.90M derived: sum of 2 quarters · filed 2017-09-07 | -$16.81M derived: sum of 3 quarters · filed 2017-09-07 | -$39.81M 10-K · filed 2017-09-07 | |
| 2016-03-31 | -$24.95M 10-Q · filed 2017-05-10 | -$22.86M derived: sum of 2 quarters · filed 2017-05-10 | -$45.87M 10-Q · filed 2017-05-10 | -$34.86M derived: sum of 4 quarters · filed 2017-09-07 | |
| 2015-12-31 | $2.09M 10-Q · filed 2017-02-09 | -$20.93M 10-Q · filed 2017-02-09 | -$23.93M 10-Q · filed 2016-02-09 | -$9.90M derived: sum of 3 quarters · filed 2017-09-07 | -$27.05M derived: sum of 4 quarters · filed 2017-09-07 |
| 2015-09-30 | -$23.02M 10-Q · filed 2016-11-09 | -$11.99M derived: sum of 2 quarters · filed 2017-09-07 | -$29.14M derived: sum of 3 quarters · filed 2017-09-07 | -$30.64M derived: sum of 4 quarters · filed 2017-09-07 | |
| 2015-06-30 | $11.03M derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-07 | -$6.12M derived: sum of 2 quarters · filed 2017-09-07 | -$7.61M derived: sum of 3 quarters · filed 2017-09-07 | -$25.20M 10-K · filed 2017-09-07 | |
| 2015-03-31 | -$17.14M 10-Q · filed 2016-05-10 | -$18.64M derived: sum of 2 quarters · filed 2016-05-10 | -$36.23M 10-Q · filed 2016-05-10 | -$37.71M derived: sum of 4 quarters · filed 2016-08-29 | |
| 2014-12-31 | -$1.50M 10-Q · filed 2016-02-09 | -$19.09M 10-Q · filed 2016-02-09 | -$20.57M derived: sum of 3 quarters · filed 2016-08-29 | -$14.52M derived: sum of 4 quarters · filed 2016-08-29 | |
| 2014-09-30 | -$17.59M 10-Q · filed 2015-11-09 | -$19.07M derived: sum of 2 quarters · filed 2016-08-29 | -$13.03M derived: sum of 3 quarters · filed 2016-08-29 | -$8.66M derived: sum of 4 quarters · filed 2016-08-29 | |
| 2014-06-30 | -$1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-29 | $4.57M derived: sum of 2 quarters · filed 2016-08-29 | $8.93M derived: sum of 3 quarters · filed 2016-08-29 | -$19.94M 10-K · filed 2016-08-29 | |
| 2014-03-31 | $6.04M 10-Q · filed 2015-05-11 | $10.41M derived: sum of 2 quarters · filed 2015-05-11 | -$18.46M 10-Q · filed 2015-05-11 | -$16.75M derived: sum of 4 quarters · filed 2015-08-31 | |
| 2013-12-31 | $4.37M 10-Q · filed 2015-02-09 | -$24.51M 10-Q · filed 2015-02-09 | -$22.79M derived: sum of 3 quarters · filed 2015-08-31 | -$20.20M derived: sum of 4 quarters · filed 2015-08-31 | |
| 2013-09-30 | -$28.87M 10-Q · filed 2014-11-10 | -$27.16M derived: sum of 2 quarters · filed 2015-08-31 | -$24.57M derived: sum of 3 quarters · filed 2015-08-31 | -$26.46M derived: sum of 4 quarters · filed 2015-08-31 | |
| 2013-06-30 | $1.72M derived: 10-K 12 month − 10-Q 9 month · filed 2015-08-31 | $4.30M derived: sum of 2 quarters · filed 2015-08-31 | $2.41M derived: sum of 3 quarters · filed 2015-08-31 | -$7.22M 10-K · filed 2015-08-31 | |
| 2013-03-31 | $2.59M 10-Q · filed 2014-05-12 | $696.00K derived: sum of 2 quarters · filed 2014-05-12 | -$8.94M 10-Q · filed 2014-05-12 | $5.96M derived: sum of 4 quarters · filed 2014-08-29 | |
| 2012-12-31 | -$1.89M 10-Q · filed 2014-02-04 | -$11.53M 10-Q · filed 2014-02-04 | $3.37M derived: sum of 3 quarters · filed 2014-08-29 | $31.15M derived: sum of 4 quarters · filed 2014-08-29 | |
| 2012-09-30 | -$9.63M 10-Q · filed 2013-11-12 | $5.26M derived: sum of 2 quarters · filed 2014-08-29 | $33.05M derived: sum of 3 quarters · filed 2014-08-29 | $32.36M derived: sum of 4 quarters · filed 2014-08-29 | |
| 2012-06-30 | $14.90M derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-29 | $42.68M derived: sum of 2 quarters · filed 2014-08-29 | $41.99M derived: sum of 3 quarters · filed 2014-08-29 | $38.07M 10-K · filed 2014-08-29 | |
| 2012-03-31 | $27.78M 10-Q · filed 2013-05-10 | $27.10M derived: sum of 2 quarters · filed 2013-05-10 | $23.17M 10-Q · filed 2013-05-10 | ||
| 2011-12-31 | -$684.00K 10-Q · filed 2013-02-11 | -$4.61M 10-Q · filed 2013-02-11 | |||
| 2011-09-30 | -$3.93M 10-Q · filed 2012-11-09 | ||||
| 2011-06-30 | $4.94M 10-K · filed 2013-08-29 | ||||
| 2010-06-30 | -$13.76M 10-K · filed 2012-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |